{
  "id": 8016698,
  "title": "Lilly-backed Orbis does up to $1.4B macrocycle deal with Novo",
  "url": "https://urgent.news/2026/09/17/lilly-backed-orbis-does-up-to-1-4b-macrocycle-deal-with-novo",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T11:00:05.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/lilly-backed-orbis-does-up-to-1-4b-macrocycle-deal-with-novo/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Orbis Medicines will help Novo create macrocycles — those ring-shaped molecules that marry the best of antibodies and small molecules — for cardiometabolic diseases as part of an up to $1.4 billion alliance. The Thursday morning pact ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Rocket's Danon plans; Novo leaves Ascendis; Lilly's latest deal",
        "url": "https://urgent.news/2026/09/15/rockets-danon-plans-novo-leaves-ascendis-lillys-latest-deal",
        "published": "2026-09-15T15:19:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}